S1226
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
SolAeroMed Inc.
Overview
S1226 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
S1226 clinical trials
Explore related
Medical disclaimer. This page summarizes research about S1226 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.